Results 211 to 220 of about 2,909,976 (331)

Prognostic value of glioma-associated oncogene homolog 1 and SET domain-containing protein 2 immunohistochemical scores in locally advanced cervical cancer. [PDF]

Oncol Lett
De La Cruz-Hernández E, Morales-Sandoval GC, Lizano M, Avilés-Salas A, Castro-Muñoz LJ, Carrillo-García A, Ramos-Godinez MDP, Coronel-Martinez JA, Contreras-Paredes A.   +8 more
europepmc   +1 more source

Estimation and Comparison of Epiphyte Loading on Holopelagic Sargassum fluitans Collected in the North Atlantic Ocean and the Gulf of Mexico

, 2019
Sarah Shadle, Olivia Lestrade, Franziska Elmer, Frank J. Hernandez   +3 more
openalex   +2 more sources

Exposure to occupational inhalants and the risk of developing rheumatoid arthritis: A systematic review and meta‐analysis

Arthritis &Rheumatology, Accepted Article.
Objective: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint pain, swelling, and stiffness. While smoking is a well‐established risk factor for RA, the role of occupational inhalants in RA development is less well recognized.
Qianwen Liu, Xin Song, Emily Mauro, Yuan Jiang, Klementy Shchetynsky, PLars Klareskog, Lars Alfredsson, Xia Jiang   +7 more
wiley   +1 more source

[Risk factors associated with maternal and child pertussis vaccination coverage in MexicoFatores de risco associados à vacinação materno-infantil contra a pertússis no México]. [PDF]

Rev Panam Salud Publica
Silva Dirzo M, Castillo Bejarano JI, Ortega Riosvelasco F, Pérez Campos IS, Galán García E, Reyes Velázquez S, Aragón Nogales R, García Pérez R, Casillas Casillas MC, Guadarrama Rivera L, Carmona Vargas AJ, Domínguez-Barrera C, Jiménez Huerta A, Minero Hibert MÁ, Sánchez Carrillo YH, Espinoza Segura PN, Martínez Bustamante ME, Cisneros Saldaña D, Arcos Viscarra PS, Berumen Millán V.   +19 more
europepmc   +1 more source

Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring

Arthritis &Rheumatology, Accepted Article.
Background Using hydroxychloroquine (HCQ) dose of 5 mg/kg/day in systemic lupus erythematosus (SLE) is associated with a higher risk of flares; HCQ blood level monitoring could be a better way to adjust HCQ dose. We studied the upper threshold for a reference range of HCQ levels to inform routine monitoring.
Shivani Garg, Benoît Blanchet, Yann Nguyen, Fauzia Hollnagel, Ada Clarke, Michelle Petri, Murray B. Urowitz, John G. Hanly, Caroline Gordon, Sang‐Cheol Bae, Juanita Romero‐Diaz, Jorge Sanchez‐Guerrero, Ann E. Clarke, Sasha Bernatsky, Daniel J. Wallace, David A. Isenberg, Anisur Rahman, Joan T. Merrill, Paul R. Fortin, Dafna D. Gladman, Ian N. Bruce, Ellen M. Ginzler, Mary Anne Dooley, Rosalind Ramsey‐Goldman, Susan Manzi, Andreas Jönsen, Graciela S. Alarcón, Ronald F. Van Vollenhoven, Cynthia Aranow, Véronique Le Guern, Meggan Mackay, Guillermo Ruiz‐Irastorza, S. Sam Lim, Murat Inanc, Kenneth C. Kalunian, Søren Jacobsen, Christine A. Peschken, Diane L. Kamen, Anca Askanase, Jill Buyon, Julie Chezel, Alicja Puszkiel, Nathalie Costedoat‐Chalumeau   +42 more
wiley   +1 more source

Digital Health Communication and Vaccine Confidence in Mexico Using Aggregated Randomized Brand Lift Studies: Secondary Analysis. [PDF]

JMIR Form Res
Muñoz Cordero B, Romero Feregrino R, Romero Feregrino R, Romero Cabello R, Rocha Rocha VM, Martinez-Medina R, Fernández Urrutia LA.   +6 more
europepmc   +1 more source

Adiposity, biological markers of disease, and insulin resistance in Mexican American adolescents, 2004-2005.

, 2011
Anne R. Rentfro, Jeanette C. Nino, Rosa M. Pones, Wendy Innis‐Whitehouse, Cristina S. Barroso, Mohammed Rahbar, Joseph B. McCormick, Susan P. Fisher‐Hoch   +7 more
openalex   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP‐SC Study

Arthritis &Rheumatology, Accepted Article.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate‐to‐severe SLE activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly for 52 weeks (1:1 ...
Susan Manzi, Ian N. Bruce, Eric F. Morand, Richard Furie, Yoshiya Tanaka, Kenneth C. Kalunian, Anca Askanase, Patricia Puzio, Emon Khan, Jenny Wissmar, Michael Song, Catharina Lindholm, The TULIP‐SC investigators   +12 more
wiley   +1 more source

Correction: Ortiz-Islas et al. Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy. <i>Pharmaceutics</i> 2025, <i>17</i>, 128. [PDF]

Pharmaceutics
Ortiz-Islas E, Montes P, Rodríguez-Pérez CE, Ruiz-Sánchez E, Sánchez-Barbosa T, Pichardo-Rojas D, Zavala-Tecuapetla C, Carvajal-Aguilera K, Campos-Peña V.   +8 more
europepmc   +1 more source

Reconocimiento a revisores y dictaminadores

Salud Pública de México, 2015
Salud Pública de México
doaj